bioXXmed AG (FRA:T5O0)
0.0220
-0.0180 (-45.00%)
At close: Dec 4, 2025
bioXXmed AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 0.08 | 0.25 | 0.61 | 1.84 | 0 | 1.57 | Upgrade
|
| Cash & Short-Term Investments | 0.08 | 0.25 | 0.61 | 1.84 | 0 | 1.57 | Upgrade
|
| Cash Growth | -11.97% | -58.58% | -66.69% | 347701.70% | -99.97% | -21.88% | Upgrade
|
| Other Receivables | 0.02 | 0 | - | 0.04 | 0.04 | 0 | Upgrade
|
| Receivables | 0.02 | 0 | - | 0.04 | 0.04 | 0 | Upgrade
|
| Other Current Assets | 0.04 | 0.07 | 0.07 | 0.05 | 0.06 | 0.11 | Upgrade
|
| Total Current Assets | 0.14 | 0.33 | 0.68 | 1.94 | 0.1 | 1.68 | Upgrade
|
| Property, Plant & Equipment | - | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Long-Term Investments | 0.16 | 0.16 | 0 | 19.65 | 18.15 | 20.5 | Upgrade
|
| Other Intangible Assets | - | 0 | 0 | 0 | 0 | 0.05 | Upgrade
|
| Other Long-Term Assets | 0.01 | - | - | 0.02 | 0.01 | 0.04 | Upgrade
|
| Total Assets | 0.31 | 0.49 | 0.68 | 21.61 | 18.27 | 22.3 | Upgrade
|
| Accounts Payable | - | 0.08 | 0.09 | 0.03 | 0.1 | 0.1 | Upgrade
|
| Accrued Expenses | 0.05 | - | - | 0.05 | 0.05 | 0.22 | Upgrade
|
| Current Income Taxes Payable | 0 | - | - | 0.04 | 0.04 | - | Upgrade
|
| Other Current Liabilities | 0.01 | - | - | 0.01 | 0.08 | 0.04 | Upgrade
|
| Total Current Liabilities | 0.07 | 0.08 | 0.09 | 0.14 | 0.27 | 0.36 | Upgrade
|
| Long-Term Debt | 0.14 | - | 0.01 | - | 0.12 | - | Upgrade
|
| Other Long-Term Liabilities | 0.04 | 0.09 | 0.11 | 0.05 | 0.01 | 0.01 | Upgrade
|
| Total Liabilities | 0.24 | 0.17 | 0.21 | 0.19 | 0.4 | 0.37 | Upgrade
|
| Common Stock | 1.36 | 1.36 | 5.14 | 5.14 | 4.03 | 4.03 | Upgrade
|
| Additional Paid-In Capital | - | - | - | - | 34.02 | - | Upgrade
|
| Retained Earnings | -43.65 | -43.4 | -42.4 | -21.45 | -20.62 | -16.56 | Upgrade
|
| Comprehensive Income & Other | 42.36 | 42.36 | 37.73 | 37.73 | 0.44 | 34.46 | Upgrade
|
| Shareholders' Equity | 0.06 | 0.32 | 0.47 | 21.42 | 17.87 | 21.93 | Upgrade
|
| Total Liabilities & Equity | 0.31 | 0.49 | 0.68 | 21.61 | 18.27 | 22.3 | Upgrade
|
| Total Debt | 0.14 | - | 0.01 | - | 0.12 | - | Upgrade
|
| Net Cash (Debt) | -0.06 | 0.25 | 0.61 | 1.84 | -0.12 | 1.57 | Upgrade
|
| Net Cash Growth | - | -58.08% | -67.09% | - | - | -21.88% | Upgrade
|
| Net Cash Per Share | -0.04 | 0.19 | 1.18 | 3.58 | -0.30 | 3.90 | Upgrade
|
| Filing Date Shares Outstanding | 1.36 | 1.36 | 0.51 | 0.51 | 0.4 | 0.4 | Upgrade
|
| Total Common Shares Outstanding | 1.36 | 1.36 | 0.51 | 0.51 | 0.4 | 0.4 | Upgrade
|
| Working Capital | 0.07 | 0.25 | 0.59 | 1.8 | -0.17 | 1.32 | Upgrade
|
| Book Value Per Share | 0.05 | 0.23 | 0.91 | 41.69 | 44.36 | 54.43 | Upgrade
|
| Tangible Book Value | 0.06 | 0.32 | 0.47 | 21.42 | 17.87 | 21.87 | Upgrade
|
| Tangible Book Value Per Share | 0.05 | 0.23 | 0.91 | 41.69 | 44.36 | 54.30 | Upgrade
|
| Machinery | - | 0.01 | 0.01 | 0.01 | - | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.